Loading

Commentary Open Access
Volume 5 | Issue 1 | DOI: https://doi.org/10.46439/allergy.5.039

Selective antibody deficiency syndrome, response to vaccines, diagnosis, and treatment

  • 1Allergy and Clinical Immunology Service, Hospital Juárez de México, Mexico City, Mexico
  • 2Medical Director, Hospital Juárez de México, Mexico City, Mexico
  • 3Infectology Service, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico
+ Affiliations - Affiliations

Corresponding Author

Alonso-Bello César Daniel, cesar_alonso86@hotmail.com

Received Date: October 05, 2023

Accepted Date: December 28, 2023

Abstract

Selective antibody deficiency syndrome (SAD), is a primary immunodeficiency in which immunoglobulin levels remain normal, but there is a reduced response to polysaccharide antigens after vaccination. SAD is recognized by the International Union of Immunology Societies as a primary immunodeficiency of unknown genetic cause. Patients with SAD are highly susceptible to severe respiratory tract infections with encapsulated bacteria. The infections found in SAD are similar to other antibody deficiencies; patients often present with recurrent upper and lower respiratory tract infections, otitis media, and sinusitis. The treatment of this pathology is based on preventing recurrent infections by known microorganisms, and in the case of serious infections, the use of intravenous or subcutaneous immunoglobulin.

Keywords

Specific antibody deficiency, Chronic rhinosinusitis, Immune deficiency, Immunoglobulin replacement therapy, Pneumococcal antibody concentration.

Author Information X